Jessica N. Abraham | Designer. Writer. Publicist.

19+ Years of Expertise in Digital Marketing, Social Branding and Public Relations.

  • Home
  • Contact
  • About
  • Home
  • Contact
  • About

No Widgets found in the Sidebar Alt!

  • What is ImQuest, and How is Statera Biopharma using it to Develop New Immune Therapies for Cancer, Infectious Disease and Autoimmune Disorders?
    Business,  Benzinga,  Biotechnology,  Finance,  Health

    What is ImQuest, and How is Statera Biopharma using it to Develop New Immune Therapies for Cancer, Infectious Disease and Autoimmune Disorders?

    September 8, 2021 /

    Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Statera Biopharma, Inc. (NASDAQ: STAB) — the company formerly known as Cytocom (NASDAQ: CBLI) — recently uplisted to the Nasdaq in lieu of earlier acquisitions involving Cleveland BioLabs and ImQuest Life Sciences, Inc. Last week, the company provided an update on its integration of ImQuest and its plans going forward.  According to Statera, preclinical testing is underway in the screening of second-generation immune therapies using the ImQuest platform for the rapid and accurate assessment of various diseases and how the overall makeup and composition of these diseases interact. The company will look more closely…

    read more
    Jessica N. Abraham Comments Off on What is ImQuest, and How is Statera Biopharma using it to Develop New Immune Therapies for Cancer, Infectious Disease and Autoimmune Disorders?

    You May Also Like

    Healthcare Apps, Unified Communications, WebRTC, IoT, RFID, Healthcare Solutions, RTC, Web RTC, Real Time Communications, Unified Communications, Remote Collaboration, Enterprise Collaboration, Enterprise Solutions, Business Solutions, Contact Center, Remote Workforce, TMC Net, TMCNet, Technology News, Tech News, Technology Marketing News,

    Predictions for Real Estate 2016: How Agents and Facilities Managers Will Benefit

    December 22, 2015
    Screen Shot 2018 11 06 at 1.43.04 AM Future Market Insights recently broke down five trends in the Global Natural Language Processing market that we can expect in the next ten years. Here is a quick look at those:

    5 Global Natural Language Processing Trends & Why the Market is Booming

    February 19, 2016
    chuck e cheese, cec entertainment, winner winner app, business, covid-19, bankruptcy, businesses in bankruptcy, coronavirus

    Could reinventing family fun serve as a lifeline in Chuck E. Cheese’s current bankruptcy case?

    September 24, 2020
  • Statera Biopharmaceuticals, Groundbreaking Biomedicine Treatment
    Health,  Benzinga,  Biotechnology,  Business,  Finance

    Statera BioPharma: The Ticker Formerly Known as CBLI

    September 7, 2021 /

    Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. On September 1, 2021, Cytocom officially became listed as Statera BioPharma, Inc. (NASDAQ: STAB), as it updated its ticker symbol from CLBI to STAB within the Nasdaq markets.  This change in name comes as a natural progression, as the company shifts gears toward placing a more strategic focus on restoring total immune health — including autoimmune and inflammatory diseases, such as fibromyalgia and multiple sclerosis, blood disorders like anemia and lupus, even cancer and various other infectious diseases.  The company began trading as CLBI, last month,…

    read more
    Jessica N. Abraham Comments Off on Statera BioPharma: The Ticker Formerly Known as CBLI

    You May Also Like

    What's the difference between Marijuana, Cannabis and Hemp -- industrial Hemp, CBD, Farm Bill, Agricultural Act, Generation Hemp, GENH

    Cannabis Investors Should Know the Difference Between Marijuana and Hemp

    July 19, 2021
    MedTech, HealthTech, Benzinga, BioSig Technologies, BioPharmaceuticals, Jessica Abraham, Jessica N Abraham,

    MedTech Company BioSig Technologies Deploys Disruptive Technology To Improve Arrhythmia Care

    April 7, 2022
    Age-Related Macular Degeneration DRY AMD, Lineage Cell Therapeutics

    Age-Related Macular Degeneration: What is Dry AMD, and How is Lineage Cell Therapeutics Changing the Game?

    August 11, 2021
  • Business
  • Technology
  • Career Development
  • Education
  • Entertainment
  • Fashion
  • Relationships
  • Tips
  • Travel
Ashe Theme by WP Royal.